NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea

Not Yet RecruitingN/A

Sponsor: AstraZeneca

Conditions: Severe Asthma, Chronic Rhinosinusitis With Nasal Polyps(CRSwNP)

The objectives of this study are to describe the incidence of adverse events and the effectiveness of tezepelumab in patients receiving tezepelumab as indicated for severe asthma or CRSwNP in South Korea.

Eligibility overview

Sex: ALL

Age: 12 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

1. Patients who are treated with at least one dose of tezepelumab according to the indication in the locally approved prescribing information
2. Patients with evidence of a personally signed and dated informed consent document indicating that the patient (or a legally acceptable representative) has been informed of all pertinent aspects of the study

Exclusion Criteria:

1. Other off-label indications according to the locally approved prescribing information
2. Current participation in any interventional trial